![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A Randomized, Double-Blind, Placebo Controlled,
Parallel-Group, Phase II Trial of JKB-121 for the Treatment of
Nonalcoholic Steatohepatitis (NASH)
|
|
|
International Liver Congress™ 2018,
European Association for the Study of the Liver (EASL)
April 11th-15th, 2018
Paris, France
Anna Mae Diehl, Stephen Harrison, Stephen Caldwell, Mary Rinella, Angelo Paredes,
Cynthia A. Moylan, Cynthia D. Guy, Mustafa R. Bashir, Ying Wang,
Loren Miller*, Anchi Chang*, Edwin SC Wu*, Manal F. Abdelmalek
Funding Organization: TaiwanJ Pharmaceuticals*
![AASDL1](../images%20/041918/041918-5/AASDL1.gif)
![AASDL2](../images%20/041918/041918-5/AASDL2.gif)
![AASDL3](../images%20/041918/041918-5/AASDL3.gif)
![AASDL4](../images%20/041918/041918-5/AASDL4.gif)
![AASDL5](../images%20/041918/041918-5/AASDL5.gif)
![AASDL6](../images%20/041918/041918-5/AASDL6.gif)
![AASDL7](../images%20/041918/041918-5/AASDL7.gif)
![AASDL8](../images%20/041918/041918-5/AASDL8.gif)
![AASDL9](../images%20/041918/041918-5/AASDL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|